ARGA Investment Management LP Invests $16 Million in Bath & Body Works, Inc. $BBWI

ARGA Investment Management LP acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 621,078 shares of the company’s stock, valued at approximately $15,999,000. ARGA Investment Management LP owned 0.30% of Bath & Body Works at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of BBWI. Parkside Financial Bank & Trust grew its stake in shares of Bath & Body Works by 24.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after purchasing an additional 364 shares during the period. Parallel Advisors LLC grew its position in Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after buying an additional 481 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its holdings in Bath & Body Works by 3.7% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock valued at $430,000 after buying an additional 600 shares during the last quarter. State of Wyoming raised its position in Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after acquiring an additional 661 shares during the period. Finally, Vident Advisory LLC boosted its stake in shares of Bath & Body Works by 2.8% during the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after acquiring an additional 692 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of recent research reports. Citigroup decreased their target price on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating on the stock in a report on Friday, November 21st. Deutsche Bank Aktiengesellschaft initiated coverage on Bath & Body Works in a research note on Thursday, January 8th. They issued a “hold” rating and a $21.00 price objective on the stock. Bank of America cut their price objective on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a research note on Thursday, November 20th. Barclays increased their target price on shares of Bath & Body Works from $18.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 6th. Finally, New Street Research set a $26.00 price target on shares of Bath & Body Works in a report on Monday, November 24th. Five analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $23.53.

Key Headlines Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Zacks upgraded BBWI from “strong sell” to “hold,” which could temper selling pressure by some investors. Zacks Upgrade
• Neutral Sentiment: Brokerage consensus remains a “hold,” indicating analysts are not broadly bullish despite volatility. Consensus Hold
• Negative Sentiment: Multiple national law firms have filed or announced investigations and are soliciting lead plaintiffs in a securities‑class action alleging material misstatements/omissions covering June 4, 2024–Nov. 19, 2025 — raising the prospect of litigation costs, management distraction and reputational damage. Schall Law Firm Notice
• Negative Sentiment: Bleichmar Fonti & Auld and other firms cite a significant prior stock drop (reports reference a ~24% plunge) tied to the alleged disclosures, and are urging investors to contact counsel — this amplifies near‑term selling and uncertainty. BFA Fraud Alert
• Negative Sentiment: Additional plaintiff firms (Kessler Topaz, Rosen, Levi & Korsinsky, Bragar, Pomerantz, Faruqi, Kaplan Fox, and others) have issued alerts and deadline reminders for lead‑plaintiff motions (mid‑March deadlines), signaling broad, coordinated litigation activity. Kessler Topaz Alert

Bath & Body Works Trading Down 1.8%

NYSE BBWI opened at $22.17 on Friday. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $41.87. The stock has a market cap of $4.54 billion, a PE ratio of 6.82, a P/E/G ratio of 0.82 and a beta of 1.51. The stock’s 50 day moving average is $20.14 and its 200 day moving average is $25.17.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the firm posted $0.49 EPS. Bath & Body Works’s quarterly revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Friday, November 21st were given a dividend of $0.20 per share. The ex-dividend date was Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.6%. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Insider Transactions at Bath & Body Works

In other news, Director Francis Hondal acquired 3,343 shares of Bath & Body Works stock in a transaction on Friday, November 21st. The shares were acquired at an average price of $14.99 per share, with a total value of $50,111.57. Following the purchase, the director directly owned 21,554 shares in the company, valued at $323,094.46. The trade was a 18.36% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Lucy Brady acquired 3,470 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $14.40 per share, for a total transaction of $49,968.00. Following the completion of the acquisition, the director directly owned 17,482 shares in the company, valued at approximately $251,740.80. This represents a 24.76% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders bought 33,513 shares of company stock valued at $500,442. 0.26% of the stock is owned by company insiders.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.